Akdital (AKT) Q1 2023 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2023 earnings summary
22 Oct, 2026Executive summary
Q1 2023 revenue reached MAD 380M, up 81% YoY, alongside network expansion to 2,022 beds.
Capacity additions and higher admissions supported growth; quarterly investments rose to MAD 247M as net debt increased to MAD 672M.
Financial highlights
Revenue was MAD 380M in Q1 2023 vs MAD 210M in Q1 2022, up 81% YoY.
Separate statutory-account indicators: revenue was MAD 9M vs MAD 6M (+50%); investments were MAD 0.4M.
Patient admissions totaled 83,988 vs 46,180 in Q1 2022; headcount was 3,506 vs 1,797.
Outlook and guidance
Partnerships are expected to be consolidated in 2023 ahead of a significant investment programme in 2024–2025 to expand the footprint across Morocco.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Akdital
- Revenue rose 84% as expansion lifted net debt and the 2024 target to 34 facilities.AKT
H2 2023 - Revenue rose 61% as capacity expansion continued and net debt edged lower.AKTQ1 2024
- H1 revenue rose 51% as net income climbed 70%, with 51 hospitals targeted by 2026.AKTH1 2024
- H1 revenue grew 51% as clinic expansion lifted capacity to 2,698 beds.AKTQ2 2024
- Nine-month revenue rose 86% as expansion lifted activity and investment.AKTQ3 2023
- Revenue rose 54.9%, EBITDA grew 64.3%, and 12 facilities opened in 2024.AKTH2 2024
- Revenue rose 68% as three openings added 405 beds; net debt climbed 65%.AKTH1 2025
- Revenue rose 49% as expansion accelerated, while margins eased and net debt increased.AKTH2 2025
- Revenue rose 21% as the network expanded and Saudi hospital operations launched.AKTH1 2026